BANK VONTOBEL/PUT/EDWARDS LIFESCIENCES/65/0.1/20.09.24 | Delayed Deutsche Boerse AG 05:10:50 24/06/2024 pm IST | ||
| 0.013 EUR | -23.53% |
|
| Current month | -51.43% | ||
| 1 month | +6.25% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about EDWARDS LIFESCIENCES CORPORATION
More news
| Date | Price | Change |
|---|---|---|
| 24/24/24 | 0.013 | -23.53% |
| 21/24/21 | 0.017 | +6.25% |
| 20/24/20 | 0.016 | -42.86% |
| 19/24/19 | 0.028 | +16.67% |
| 18/24/18 | 0.024 | -20.00% |
Delayed Quote Deutsche Boerse AG
Last update June 24, 2024 at 05:10 pm IST
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | PUT |
| Underlying | EDWARDS LIFESCIENCES CORPORATION |
| Issuer | 
Vontobel
|
| WKN | VM8P1Z |
| ISIN | DE000VM8P1Z5 |
| Date issued | 18/01/2024 |
| Strike | 65 $ |
| Maturity | 20/09/2024 (88 Days) |
| Parity | 10 : 1 |
| Emission price | 0.33 € |
| Emission volume | N/A |
| Settlement | Barausgleich |
| Currency | EUR |
Technical Indicators
| Highest since issue | 0.36 € |
|---|---|
| Lowest since issue | 0.01 € |
| Spread | 0.013 € |
| Spread % | 50.00% |
Company Profile
Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows:
- heart valves and surgery products (67.9%);
- hemodynamic monitoring systems (15.5%);
- other (16.6%): balloon catheters, artificial implants, etc.
Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).
Sector
-
Ratings for Edwards Lifesciences Corporation
Trading Rating
Investor Rating
ESG Refinitiv
B+
Consensus: Edwards Lifesciences Corporation
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
31
Last Close Price
90.9
USD
Average target price
96.05
USD
Spread / Average Target
+5.67%
- Stock Market
- Warrants
- Warrant
